STR: News Releases

	Connecticut Innovations Makes $500,000 Investment in Soft Tissue Regeneration Inc. http://www.ctinnovations.com/news/439.php
	Stamford, CT, September 9, 2009 - Soft Tissue Regeneration, Inc. has been chosen by the Connecticut Technology Council as a 2009 Company to Watch as part of the Third Annual Cantor Colburn / CAAT Innovation Pipeline Awards. Link: [PDF]
	February 4, 2009. The President and CEO of Soft Tissue Regeneration, Inc., Mr. Joseph W. Reilly, has been selected to present at the Corporate Venture Capital Summit http://youngstartup.com/corporate09/overview.php at the British Consulate in Cambridge, MA on February 24, 2009. The 2009 Corporate Venture Capital Summit, now in its fifth year, has become recognized as the premier venue for venture capitalists, Startups and Corporate Development Officers to meet, interact and network with leading Corporate VCs and Strategic Investors. More than 24 leading VCs will speak at the Summit. These top-tier venture investors will discuss: VC investment trends, strategies for investing in early stage ventures, strategies for finding and accessing capital, what they look for in early stage companies, the kinds of companies they find most attractive, and the do's and don'ts in structuring deals.
	February 3, 2009. Mr. Joseph W. Reilly, the President and CEO of Soft Tissue Regeneration, Inc. has been selected to present at the Wharton Health Care Conference http://www.whcbc.org/index.asp on February 20, 2009, at the Park Hyatt at the Bellevue, Philadelphia, PA. The Wharton Health Care Business Conference, started in 1996, is a leading health care forum for industry professionals, academics, and students. The annual two-day event typically attracts over 700 attendees across the nation. These individuals represent a diverse set of sectors, from suppliers (pharmaceuticals, biotech, and medical devices) to healthcare delivery and services, as well as a broad range of functions, from marketing to business development to investors. This Year's Theme: Catalyzing Change will explore how companies and individuals are staying ahead of the curve through proactively leading change in an increasingly dynamic field. Example topics include the convergence of pharmaceutical and biotechnology, medical device industry globalization, health care reform with a new political administration, and the challenges associated with financing in a constrained economy.
	February 2, 2009. Dr. Mark T. Aronson, Senior Scientist of Soft Tissue Regeneration, Inc. will present at the 6th Annual McGuire Woods Health Care and Life Sciences Private Equity Conference in Chicago on February 26, 2009. The conference will be held at the Palmer House Hilton in Chicago, IL.
	On September 2, 2008, Soft Tissue Regeneration, Inc. announced that it has closed on a $3.5 million Series A financing led by MentorTech Ventures (Philadelphia, PA). Link: [PDF Document]
	July 23, 2008 - ESPN - 7 things You Should Know About by Dr. James Andrews, Soft Tissue Regeneration Board Member. Link: [HTML] (opens in a new window)
	June 11, 2008 – Helsinki Finland - The 2008 Millennium Technology Prize was presented to Soft Tissue Regeneration, LLC Board of Directors Member and Scientific Advisory Board Member, Professor Robert Langer today in Helsinki for developing innovative biomaterials for controlled drug release. Link: [HTML] (opens in a new window)
	April 22, 2008 – Herndon, Va. – The Center for Innovative Technology (CIT) today announced that CIT GAP Funds is leading an investment round in Soft Tissue Regeneration, LLC (STR), a medical device company based in Earlysville, VA, that develops synthetic scaffolds to encourage tissue regeneration. Links: [HTML] [Word Document]